Vivian de Jong

PHD Candidate - OIO

Contact

Recent publications

Lipid Profiles in Liver Steatosis and Liver Fibrosis in Patients with Type 2 Diabetes and Coronary Artery Disease Laura A.M. Konings, Weiwei Xu, Vivian D. de Jong, Marco Alings, Jean Claude Tardif, Abraham M. Lincoff, Gregory G. Schwartz, Diederick E. Grobbee, Manuel Castro Cabezas
Diabetology, 2026, vol. 7, p.1-15

Metabolic dysfunction-associated steatotic liver disease (MASLD) screening strategies: from non-invasive tests to multidisciplinary care models Vivian de Jong
2026

Care Pathways for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Kirsi M A van Eekhout, Leonard D Broekman, Vivian D de Jong, Maurice Michel, Rick Grobbee, Douglas Maya-Miles, Manuel Romero-Gómez, Jean Muris, Juan M Mendive, Yasaman Vali, Oscar H Franco, Jörn M Schattenberg, Céline Fournier-Poizat, Manuel Castro Cabezas, Maarten E Tushuizen, Adriaan G Holleboom
Liver International, 2026, vol. 46

Genetic risk factors for MASLD/MASH and cardiovascular disease in elderly individuals Willy B Theel, Vivian D de Jong, Diederick E Grobbee, J Wouter Jukema, Stella Trompet, Manuel Castro Cabezas
Annals of Hepatology, 2025, vol. 31

Liver Fibrosis as a Predictor of Cardiovascular Risk in Patients with Severe Obesity Alina N Saidi, Willy B Theel, Vivian D de Jong, Stefanie R van Mil, Aart-Jan van der Lely, Diederick E Grobbee, Jan Apers, Ellen van der Zwan-van Beek, Manuel Castro Cabezas
Journal of Clinical medicine, 2025, vol. 14

Assessing the effects of naltrexone-bupropion on hepatic steatosis and fibrosis in patients with T2DM and overweight or obesity Alina N Saidi, Laura A M Konings, Carmen A W Dietvorst, Vivian D de Jong, Willem Pieter Brouwer, Aart-Jan van der Lelij, Marco Alings, Martien van Wenum, Simone P Rauh, Weiwei Xu, Manuel Castro Cabezas
Diabetes, Obesity & Metabolism, 2025, vol. 27, p.6624-6631